Assignee
INVENTIVA
FR·8 granted patents·8 pending applications·10 citations·filing 2014–2025
Top patents by PatentIndex Score
16 records- 0185US11504380B2Method of treatment of cirrhosisINVENTIVA·Filed 2019·Granted Nov 22, 2022·3 cites·7 claims
- 0277US10052311B2PPAR compounds for use in the treatment of fibrotic diseasesINVENTIVA·Filed 2015·Granted Aug 21, 2018·3 cites·10 claims
- 0376US10383858B2PPAR compounds for use in the treatment of fibrotic diseasesINVENTIVA·Filed 2018·Granted Aug 20, 2019·2 cites·10 claims
- 0471US10414739B2Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 0569US2025263406A1Deuterated derivatives of lanifibranorINVENTIVA·Filed 2025·Application pending·0 cites
- 0665US12291526B2Deuterated derivatives of lanifibranorINVENTIVA·Filed 2019·Granted May 6, 2025·0 cites·6 claims
- 0761US2025243192A1Crystalline form of lanifibranorINVENTIVA·Filed 2023·Application pending·0 cites
- 0860US2024408069A1Non-invasive monitoring of liver disease treatmentINVENTIVA·Filed 2024·Application pending·0 cites
- 0959US2024410904A1Non-invasive monitoring of liver disease treatmentINVENTIVA·Filed 2024·Application pending·0 cites
- 1053US9561246B2Use of Odiparcil in the treatment of a mucopolysaccharidosisINVENTIVA·Filed 2014·Granted Feb 7, 2017·0 cites·11 claims
- 1152US2024016807A1Combination therapy for the treatment of a liver diseaseINVENTIVA·Filed 2021·Application pending·0 cites
- 1251US10092540B2Method of treatment of a mucopolysaccharidosisINVENTIVA·Filed 2017·Granted Oct 9, 2018·0 cites·17 claims
- 1347US2025290937A1Methods and monitoring of treatment with lanifibranorINVENTIVA·Filed 2025·Application pending·0 cites
- 1446US11999758B2Inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of cancerINVENTIVA·Filed 2019·Granted Jun 4, 2024·0 cites·19 claims
- 1534US2020115353A1New compounds inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2018·Application pending·0 cites
- 1625US2017066717A1New phenylazetidinecarboxylate or -carboxamide compoundsINVENTIVA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INVENTIVA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →